[ON THE EFFECT OF BLOOD COAGULATION INHIBITORS AND FIBRINOLYSIS ON THE SANARELLI-SHWARTZMAN PHENOMENON].
D000818:Animals; D001777:Blood Coagulation; D004731:Endotoxins; D004791:Enzyme Inhibitors; D005341:Fibrinolysin; D005342:Fibrinolysis; D006629:Hirudins; D007610:Kallikreins; D007793:Lagomorpha; D008070:Lipopolysaccharides; D010600:Pharmacology; D011817:Rabbits; D012106:Research; D012790:Shwartzman Phenomenon; D014116:Toxicology; D014361:Trypsin Inhibitors
D004731:Endotoxins; D004791:Enzyme Inhibitors; D006629:Hirudins; D008070:Lipopolysaccharides; D014361:Trypsin Inhibitors; D007610:Kallikreins; D005341:Fibrinolysin
ENDOTOXINS; ENZYME INHIBITORS; EXPERIMENTAL LAB STUDY; FIBRINOLYSIN; FIBRINOLYSIS; HIRUDIN; KALLIKREIN; LIPOPOLYSACCHARIDES; PHARMACOLOGY; RABBITS; SHWARTZMAN PHENOMENON; TOXICOLOGIC REPORT; TRYPSIN INHIBITORS
UBER DEN EINFLUSS VON HEMMSTOFFEN DER BLUTGERINNUNG UND FIBRINOLYSE AUF DAS SANARELLI-SHWARTZMAN-PHAENOMEN.